#33 JournalChat: Cirrhosis, Albumin, & ATTIRE trial with Dr. Louise China

JournalSpotting

Indhold leveret af Journalspotting. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Journalspotting eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

3+ y ago 33:19

MP3•Episode hjem

The JournalSpotters chat to the fist author of the ATTIRE trial, a big RCT looking at albumin use in cirrhosis patients.
Dr. Louise China is a senior clinical fellow at the Royal Free Hospital, London and has spent many years investigating the role of albumin in patients with liver cirrhosis.
We chat to Louise about:

An overview of decompensated cirrhosis
When to use Albumin in patients with cirrhosis
The design of the ATTIRE trial
What can we learn from the ATTIRE trial
Top tips for managing patients with cirrhosis
Advice for medics looking to get involved in research

A big thank you to Lousie for taking some time out of her busy job as a hepatologist (and her time dreaming of being back scuba diving)!
China L, Freemantle N, Forrest E, Kallis Y, Ryder SD, Wright G, Portal AJ, Becares Salles N, Gilroy DW, O'Brien A; ATTIRE Trial Investigators. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis. N Engl J Med. 2021 Mar 4;384(9):808-817. doi: 10.1056/NEJMoa2022166. PMID: 33657293.

Support the show

Visit the website on www.journalspotting.com.
Follow us on Twitter @JournalSpotting.
Email us on journalspotting@gmail.com.
Get our JournalClub App on https://journalclub.messly.com
Share us with all your colleagues!

67 episoder

#Science #Fitness #Biology #Medicine #Articles #Gim #Literature #Annals #Podcasting Education #JournalSpotting #Journalism #NHS #Hospitality #Evidence #NEJM #BMJ #JAMA